159 related articles for article (PubMed ID: 37951128)
1. Efficacy, safety, and cost-effectiveness of therapeutic drug monitoring (TDM) for TNF inhibitor therapy in rheumatic disease: A systematic review and meta-analysis.
Dong W; Hu X; Wu C; Wang G; Fang Y; Shi L; Nie X
Semin Arthritis Rheum; 2023 Dec; 63():152302. PubMed ID: 37951128
[TBL] [Abstract][Full Text] [Related]
2. Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.
Verhoef LM; van den Bemt BJ; van der Maas A; Vriezekolk JE; Hulscher ME; van den Hoogen FH; Jacobs WC; van Herwaarden N; den Broeder AA
Cochrane Database Syst Rev; 2019 May; 5(5):CD010455. PubMed ID: 31125448
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis: The efficacy of therapeutic drug monitoring of anti-TNF-therapy in inflammatory bowel disease.
Sethi S; Dias S; Kumar A; Blackwell J; Brookes MJ; Segal JP
Aliment Pharmacol Ther; 2023 Jun; 57(12):1362-1374. PubMed ID: 36495020
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.
van Herwaarden N; den Broeder AA; Jacobs W; van der Maas A; Bijlsma JW; van Vollenhoven RF; van den Bemt BJ
Cochrane Database Syst Rev; 2014 Sep; (9):CD010455. PubMed ID: 25264908
[TBL] [Abstract][Full Text] [Related]
6. Clinical Outcomes With Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Systematic Review With Meta-Analysis.
Ricciuto A; Dhaliwal J; Walters TD; Griffiths AM; Church PC
J Crohns Colitis; 2018 Nov; 12(11):1302-1315. PubMed ID: 30107416
[TBL] [Abstract][Full Text] [Related]
7. A Systematic Review on Cost-effectiveness Analyses of Therapeutic Drug Monitoring for Patients with Inflammatory Bowel Disease: From Immunosuppressive to Anti-TNF Therapy.
Yao J; Jiang X; You JHS
Inflamm Bowel Dis; 2021 Jan; 27(2):275-282. PubMed ID: 32311018
[TBL] [Abstract][Full Text] [Related]
8. Tumor Necrosis Factor Inhibitor Dose Reduction for Axial Spondyloarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Lawson DO; Eraso M; Mbuagbaw L; Joanes M; Aves T; Leenus A; Omar A; Inman RD
Arthritis Care Res (Hoboken); 2021 Jun; 73(6):861-872. PubMed ID: 32166872
[TBL] [Abstract][Full Text] [Related]
9. Is Therapeutic Drug Monitoring for Anti-tumour Necrosis Factor Agents in Adults With Inflammatory Bowel Disease Ready for Standard of Care? A Systematic Review and Meta-analysis.
Shah R; Hoffman GR; El-Dallal M; Goldowsky AM; Chen Y; Feuerstein JD
J Crohns Colitis; 2020 Sep; 14(8):1057-1065. PubMed ID: 32064510
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor inhibitors and risk of peripheral neuropathy in patients with rheumatic diseases.
Etminan M; Sodhi M; Samii A; Carleton BC; Kezouh A; Antonio Avina-Zubieta J
Semin Arthritis Rheum; 2019 Jun; 48(6):1083-1086. PubMed ID: 30337056
[TBL] [Abstract][Full Text] [Related]
11. Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.
Singh JA; Hossain A; Tanjong Ghogomu E; Mudano AS; Maxwell LJ; Buchbinder R; Lopez-Olivo MA; Suarez-Almazor ME; Tugwell P; Wells GA
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012591. PubMed ID: 28282491
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Therapeutic Drug Monitoring in the Clinical Management of Patients with Rheumatic Diseases: Data from a Retrospective Single-Center Cohort Study.
Pedersen L; Szecsi PB; Johansen PB; Bjerrum PJ
Biologics; 2020; 14():115-125. PubMed ID: 33162753
[TBL] [Abstract][Full Text] [Related]
13. Enzyme-linked immunosorbent assays for monitoring TNF-alpha inhibitors and antibody levels in people with rheumatoid arthritis: a systematic review and economic evaluation.
Tikhonova IA; Yang H; Bello S; Salmon A; Robinson S; Hemami MR; Dodman S; Kharechko A; Haigh RC; Jani M; McDonald TJ; Hoyle M
Health Technol Assess; 2021 Feb; 25(8):1-248. PubMed ID: 33555998
[TBL] [Abstract][Full Text] [Related]
14. Real-world effectiveness of biological therapy in patients with rheumatoid arthritis: Systematic review and meta-analysis.
de Castro CT; de Queiroz MJ; Albuquerque FC; Brandão CC; Gerlack LF; Pereira DCR; Barros SC; Andrade WW; Bastos EA; Azevedo JNB; Carreiro R; Barreto ML; Dos Santos DB
Front Pharmacol; 2022; 13():927179. PubMed ID: 36034836
[No Abstract] [Full Text] [Related]
15. Effect of TNF-inhibitor therapy on spinal structural progression in ankylosing spondylitis patients: A systematic review and meta-analysis.
Ajrawat P; Touma Z; Sari I; Taheri C; Diaz Martinez JP; Haroon N
Int J Rheum Dis; 2020 Jun; 23(6):728-743. PubMed ID: 32419337
[TBL] [Abstract][Full Text] [Related]
16. Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.
Syversen SW; Jørgensen KK; Goll GL; Brun MK; Sandanger Ø; Bjørlykke KH; Sexton J; Olsen IC; Gehin JE; Warren DJ; Klaasen RA; Noraberg G; Bruun TJ; Dotterud CK; Ljoså MKA; Haugen AJ; Njålla RJ; Zettel C; Ystrøm CM; Bragnes YH; Skorpe S; Thune T; Seeberg KA; Michelsen B; Blomgren IM; Strand EK; Mielnik P; Torp R; Mørk C; Kvien TK; Jahnsen J; Bolstad N; Haavardsholm EA
JAMA; 2021 Dec; 326(23):2375-2384. PubMed ID: 34932077
[TBL] [Abstract][Full Text] [Related]
17. Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA).
Singh JA; Hossain A; Tanjong Ghogomu E; Mudano AS; Tugwell P; Wells GA
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012437. PubMed ID: 27855242
[TBL] [Abstract][Full Text] [Related]
18. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
[TBL] [Abstract][Full Text] [Related]
19. Aminosalicylates for induction of remission or response in Crohn's disease.
Lim WC; Wang Y; MacDonald JK; Hanauer S
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD008870. PubMed ID: 27372735
[TBL] [Abstract][Full Text] [Related]
20. Is tumor necrosis factor-α monoclonal therapy with proactive therapeutic drug monitoring optimized for inflammatory bowel disease? Network meta-analysis.
Zheng FY; Yang KS; Min WC; Li XZ; Xing Y; Wang S; Zhang YS; Zhao QC
World J Gastrointest Surg; 2024 Feb; 16(2):571-584. PubMed ID: 38463352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
